Naveen Rao·Mar 10, 20252024 Neurotech Funding Snapshot🤑 $2.3 Billion Across 129 Deals: Analyzing a (historic) year of fundraising
Naveen Rao·Jun 14, 2023Beyond Mindfulness: “Hella Focused,” the Neuroscience of Ecstasis, and the Joy of WorkEmbracing the limits of limitlessness
Naveen Rao·Jun 9, 2023Elon Musk’s Neuralink just got FDA approval for human trials. Now what?Exploring the Business and Ethical Implications of Brain-Computing Interface (BCI) Innovation
Naveen Rao·Dec 30, 2021How should I create annual writing goals?Hint: That’s the wrong place to startA response icon1A response icon1
InTincturebyNaveen Rao·Aug 5, 2019Friends with Benefits: MA Plans Weigh in on Social DeterminantsHow does Medicare Advantage feel about Supplemental Benefits, Community Partners, and SDOH?
InTincturebyNaveen Rao·Apr 22, 2019Who, What, & How: Understanding New SDOH Payments in Medicare AdvantageEligibility, Coverage, and Determination in SSBCI
InTincturebyNaveen Rao·Apr 19, 2019At a Glance: New Z-Codes for SDOHA handy guide to commenting on proposed ICD-10 changes
InTincturebyNaveen Rao·Feb 10, 2019The 2020 Opportunity: Medicare Advantage as a Market for SDOH InnovationSupplemental Benefits Never Sounded So GoodA response icon1A response icon1